• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颌骨牙槽骨坏死的病理生理学:抗心磷脂抗体、血栓形成倾向和纤维蛋白溶解功能减退。

The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia, and hypofibrinolysis.

作者信息

Gruppo R, Glueck C J, McMahon R E, Bouquot J, Rabinovich B A, Becker A, Tracy T, Wang P

机构信息

Division of Hematology/Oncology, Children's Hospital Medical Center, Cincinnati, OH USA.

出版信息

J Lab Clin Med. 1996 May;127(5):481-8. doi: 10.1016/s0022-2143(96)90065-7.

DOI:10.1016/s0022-2143(96)90065-7
PMID:8621985
Abstract

We studied 55 patients (50 women, 5 men) with severe facial pain and biopsy-proven neuralgia-inducing cavitational osteonecrosis (NICO) of the alveolar bone of the jaws. Our aim was to assess the pathophysiologic contributions to NICO of anticardiolipin antibodies (aCLA), thrombophilia (increased tendency to intravascular thrombi), and hypofibrinolysis (reduced ability to lyse thrombi). Of the 55 patients, 43 (78%) had one or more tests positive for thrombophilia or hypofibrinolysis (or both), and only 12 (22%) were normal. Eighteen of 55 (33%) patients had high aCLA (> 2 SD above mean value for control subjects); immunoglobulin G (IgG) (p = 0.01) and immunoglobulin A (IgA)(p = 0.001) levels were higher in patients than in controls. The distribution of elevated aCLA immunoglobulin classes among patients was as follows: IgG alone, 5 (9%); IgA alone, 7 (13%); and IgM alone, 3 (5%). Three patients (5%) had high levels of both IgG and IgA aCLA. Other defects of the thrombotic or fibrinolytic systems in the 55 patients included high lipoprotein(a) in 36% (vs 20% in control subjects (p = 0.03)), low stimulated tissue plasminogen activator activity (tPA-Fx) in 22% (vs 7% in control subjects (p = 0.08)), high plasminogen activator inhibitor activity (PAI-Fx) in 18% (vs 8% in control subjects (p = 0.03)), resistance to activated protein C in 16% (vs 0% in control subjects (p = 0.007)), low antigenic protein C in 4+ (vs 0% in control subjects (p > 0.2)), and low antigenic protein S in 4% (vs 0% in control subjects (p > 0.2)). Anticardiolipin antibodies and other defects of the thrombotic and fibrinolytic systems appear to be common, potentially reversible pathogenetic risk factors associated with osteonecrosis of the jaw.

摘要

我们研究了55例(50名女性,5名男性)患有严重面部疼痛且经活检证实为颌骨牙槽骨神经痛性空洞性骨坏死(NICO)的患者。我们的目的是评估抗心磷脂抗体(aCLA)、血栓形成倾向(血管内血栓形成倾向增加)和纤维蛋白溶解功能减退(溶解血栓能力降低)对NICO的病理生理影响。在这55例患者中,43例(78%)一项或多项血栓形成倾向或纤维蛋白溶解功能减退检测呈阳性(或两者皆阳性),只有12例(22%)检测结果正常。55例患者中有18例(33%)aCLA水平较高(高于对照受试者平均值2个标准差以上);患者的免疫球蛋白G(IgG)(p = 0.01)和免疫球蛋白A(IgA)(p = 0.001)水平高于对照组。患者中aCLA免疫球蛋白类别升高的分布情况如下:单独IgG升高,5例(9%);单独IgA升高,7例(13%);单独IgM升高,3例(5%)。3例患者(5%)IgG和IgA aCLA水平均较高。55例患者血栓形成或纤维蛋白溶解系统的其他缺陷包括:36%的患者脂蛋白(a)水平较高(对照受试者为20%,p = 0.03),22%的患者刺激的组织纤溶酶原激活物活性(tPA-Fx)较低(对照受试者为7%,p = 0.08),18%的患者纤溶酶原激活物抑制剂活性(PAI-Fx)较高(对照受试者为8%,p = 0.03),16%的患者对活化蛋白C有抵抗(对照受试者为0%,p = 0.007),4%的患者抗原性蛋白C水平较低(对照受试者为0%,p > 0.2),4%的患者抗原性蛋白S水平较低(对照受试者为0%,p > 0.2)。抗心磷脂抗体以及血栓形成和纤维蛋白溶解系统的其他缺陷似乎是常见的、潜在可逆的与颌骨骨坏死相关的致病危险因素。

相似文献

1
The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia, and hypofibrinolysis.颌骨牙槽骨坏死的病理生理学:抗心磷脂抗体、血栓形成倾向和纤维蛋白溶解功能减退。
J Lab Clin Med. 1996 May;127(5):481-8. doi: 10.1016/s0022-2143(96)90065-7.
2
Thrombophilia, hypofibrinolysis, and alveolar osteonecrosis of the jaws.血栓形成倾向、纤维蛋白溶解功能减退与颌骨牙槽骨坏死
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 May;81(5):557-66. doi: 10.1016/s1079-2104(96)80047-3.
3
A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws.一项关于治疗血栓形成倾向和纤维蛋白溶解功能减退以及改善颌骨骨坏死疼痛的初步试点研究。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jan;85(1):64-73. doi: 10.1016/s1079-2104(98)90400-0.
4
Heterozygosity for the Leiden mutation of the factor V gene, a common pathoetiology for osteonecrosis of the jaw, with thrombophilia augmented by exogenous estrogens.因子V基因莱顿突变的杂合性是颌骨骨坏死的常见病因,外源性雌激素会加剧血栓形成倾向。
J Lab Clin Med. 1997 Nov;130(5):540-3. doi: 10.1016/s0022-2143(97)90132-3.
5
Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis.血栓形成倾向与纤维蛋白溶解功能减退:骨坏死的病理生理学
Clin Orthop Relat Res. 1997 Jan(334):43-56.
6
Hypofibrinolysis: a common, major cause of osteonecrosis.纤维蛋白溶解功能减退:骨坏死常见的主要病因。
Am J Hematol. 1994 Feb;45(2):156-66. doi: 10.1002/ajh.2830450212.
7
Procoagulants and osteonecrosis.促凝血剂与骨坏死
J Rheumatol. 2003 Apr;30(4):783-91.
8
Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol.特发性骨坏死、纤维蛋白溶解功能减退、高纤溶酶原激活物抑制剂、高脂蛋白(a)以及司坦唑醇治疗
Am J Hematol. 1995 Apr;48(4):213-20. doi: 10.1002/ajh.2830480402.
9
Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?伴有纤溶功能减退的家族性高纤溶酶原激活物抑制剂,是骨坏死的一种新的病理生理原因?
Thromb Haemost. 1993 May 3;69(5):460-5.
10
Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion.遗传性血栓形成倾向与纤维蛋白溶解功能减退。视网膜静脉阻塞的可能病因。
Arch Ophthalmol. 1999 Jan;117(1):43-9. doi: 10.1001/archopht.117.1.43.

引用本文的文献

1
Neuralgia Inducing Cavitational Osteonecrosis of the Jaw: Scientific Controversy or pseudoscience?引发颌骨空洞性骨坏死的神经痛:科学争议还是伪科学?
J Pain Res. 2025 Aug 24;18:4275-4284. doi: 10.2147/JPR.S533032. eCollection 2025.
2
Thrombophilia, hypofibrinolysis and osteonecrosis.血栓形成倾向、纤维蛋白溶解功能减退与骨坏死。
Orthopadie (Heidelb). 2025 May;54(5):376-385. doi: 10.1007/s00132-024-04606-3. Epub 2025 Feb 19.
3
Is preexisting inflamed jaw marrow a "hidden" co-morbidity affecting outcomes of COVID-19 infections? - Clinical comparative study.
先前存在的炎症性颌骨髓炎是否是影响 COVID-19 感染结局的“隐藏”合并症?——临床对比研究。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241265265. doi: 10.1177/03946320241265265.
4
Management of Medication-Related Osteonecrosis of the Jaw with Photobiomodulation and Minimal Surgical Intervention.采用光生物调节和微创外科手术治疗颌骨药物相关性骨坏死
Dent J (Basel). 2023 May 8;11(5):127. doi: 10.3390/dj11050127.
5
Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications.遗传性血栓形成倾向/纤溶低下患者的颌骨骨坏死:从病理生理学到治疗意义。
Int J Mol Sci. 2022 Jan 7;23(2):640. doi: 10.3390/ijms23020640.
6
Osteonecrosis of the Jaw Beyond Bisphosphonates: Are There Any Unknown Local Risk Factors?双膦酸盐类药物之外的颌骨骨坏死:是否存在未知的局部危险因素?
Clin Cosmet Investig Dent. 2021 Jan 19;13:21-37. doi: 10.2147/CCIDE.S288603. eCollection 2021.
7
Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy.抗磷脂抗体综合征继发骨坏死:病例报告、文献复习及治疗策略。
Rheumatol Int. 2010 Apr;30(6):719-23. doi: 10.1007/s00296-009-1269-9. Epub 2009 Dec 12.
8
Orthopedic involvement in antiphospholipid syndrome.抗磷脂综合征中的骨科表现
Clin Rev Allergy Immunol. 2007 Apr;32(2):167-71. doi: 10.1007/s12016-007-0006-y.